SUBSCRIBE
SUBSCRIBE
News   Policy

Elan Corporation PLC Says Report Finds No Fault; Directors to Go

September 17, 2010 | 
1 min read
DUBLIN, Sept 17 (Reuters) - The board of Elan (ELN.I) has been cleared of any wrongdoing following a controversial review by a U.S. law firm, the Irish drugmaker said on Friday, adding that two directors would resign following the inquiry.
Legal Europe
MORE ON THIS TOPIC
Pictured: Front view of the CDC museum in Georgia
CDC
RFK Jr. Appoints 2 New Advisors to CDC Vaccine Panel Ahead of March Meeting
March 2, 2026
 · 
2 min read
 · 
Tristan Manalac
The fight over the Affordable Care Act and the repeal and replace of Obamacare concept.In American politics US parties are represented by either the democrat donkey or republican elephant
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
February 27, 2026
 · 
6 min read
 · 
Heather McKenzie
Borrow money from friend, debt and loan, incentive or bonus payment, credit or lending concept, businessman hand giving money banknote to friend's hand.
FDA
FDA To Offer Bonus Payments for Speedy Drug Reviewers
February 27, 2026
 · 
1 min read
 · 
Annalee Armstrong
Digital compass. Business strategic explorer, Vision crisis, Mission path, Agency creative, Digital strategy, Market decision, Achievement strategy, Financial stock, Company vision concepts
Policy
FDA Policy Tracker 2026: One-Trial Drug Applications, Guidelines for Personalized Therapies
February 27, 2026
 · 
7 min read
 · 
BioSpace Editorial Staff